Robert Hocking is a business and brand strategist who specialises in consumer behaviour and innovation.
He’s launched a half-dozen ventures, coached innumerable early-stage businesses, and advised companies that include P&G and Unilever, Diageo and Bacardi, Motorola, Dell and IBM, in markets from North America, Africa, Western and Eastern Europe, and Asia.
In 2020, he left the UK to return to Canada where he runs a boutique consultancy that specialises in working with companies to help their business strategies be market-ready for the next 3-5 years using design thinking methodologies (he studied Design Thinking and Innovation at MIT).
In addition to his ‘day job’, he’s a Teaching Fellow at Oxford University’s Said Business School, has been a guest lecturer at the University of Edinburgh, Leeds University Business School, Delft University of Technology, University College London, and the London School of Economics.
Dr. Prism Schneider
Associate Professor, University of Calgary
Departments of Surgery & Community Health Sciences
Dr. Prism Schneider is an Associate Professor of Orthopaedic Surgery in the Departments of Surgery and Community Health Sciences, at the University of Calgary. She also holds the positions of Trauma Research Lead, Resident and Fellow Research Director, and Faculty Research Director for the Division of Orthopaedic Surgery. Dr. Schneider divides her time between active clinical practice as a traumatologist at
the Foothills Medical Centre, one of the busiest Level 1 Trauma Centres in Canada, and her research endeavours. She obtained her MD from the University of Calgary, and has completed post-graduate training including a PhD in Biomechanics and two Orthopaedic Trauma Fellowships at the University of Texas, in Houston and at McGill University, in Montreal.
Dr. Schneider’s research interests involve understanding the cellular and systemic inflammatory response to injury, including trauma-induced coagulopathy and post-traumatic joint contractures, clinical trials for optimizing surgical outcomes, and using advanced imaging to study the micro-architecture of fracture healing and dynamic imaging to evaluate post-surgical outcomes. She also has a particular interest in identifying and assisting patients who are injured due to violence in the home.
Dr. Schneider has completed several multi-centre randomized controlled trials in collaboration with the Canadian Orthopaedic Trauma Society, in order to define surgical indications following injury and to determine the optimal surgical techniques to help improve patient outcomes. Dr. Schneider’s trauma-induced coagulopathy research program is funded by the the Canadian Institutes for Health Research, the Heart and Stroke Foundation of Canada, and the Canadian Foundation for Innovation. She is an emerging leader in injury-related coagulopathy and her program aims to use a precision medicine approach to venous thromboembolism prevention.